✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Incyte Corp

Common Name
Incyte
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,844
Ticker
INCY
Exchange
Nasdaq
Description
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates...

Incyte's Financial Statements Preview

Below are the financial statements of Incyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenues
Product revenues, net
3,618.89a
3,165.17a
2,746.9a
Product royalty revenues
579.33a
523.48a
482.74a
Milestone and contract revenues
43a
7a
165a
Total revenues
4,241.22a
3,695.65a
3,394.64a
Costs, expenses and other
Cost of product revenues (including definite-lived intangible amortization)
-312.07a
-254.99a
-207a
Research and development
-2,606.85a
-1,627.59a
-1,585.94a
Selling, general and administrative
-1,242.16a
-1,161.29a
-1,002.14a
Loss on change in fair value of acquisition-related contingent consideration
-19.8a
-29.2a
-12.15a
(Profit) and loss sharing under collaboration agreements
-1.03a
2.05a
7.97a
Total costs, expenses and other
-4,179.85a
-3,075.12a
-2,815.2a
Income from operations
61.37a
620.53a
579.44a
Interest income
128.71a
158.41a
40.45a
Interest expense
-2.28a
-2.55a
-2.67a
Realized and unrealized gain (loss) on equity investments
116.03a
43.89a
-87.59a
Other, net
12.81a
13.93a
-0.52a
Income before provision for income taxes
316.63a
834.22a
529.12a
Provision for income taxes
-284.02a
-236.62a
-188.46a
Net income
32.62a
597.6a
340.66a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Incyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Incyte's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?